Public Calendar: June 19-25, 2022
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs
Event Date: 06/20/2022
Location: Virtual
Subject: Drug Information Association (DIA) 2022 Global Annual Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, academia, media, and other registered participants
Event Date: 06/22/2022
Location: Virtual
Subject: COVID-19 Vaccines for Infants and Children 6 Months and Older
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members of groups that are interested in the vaccination of children
Event Date: 06/24/2022
Location: Virtual
Subject: Aspen Ideas: Health; Speaker: Protecting the Public's Health, From Baby Formula to Vaccines
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, academia, media, and other registered guests
Event Date: 06/24/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several industry groups interested in the infant formula issue
Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner
Event Date: 06/21/2022
Location: Virtual
Subject: Drug Information Association (DIA) Global Annual Meeting
FDA Participant/Group: RONALD FITZMARTIN; GERALD DALPAN; SANDRA KWEDER;
Non FDA Participant/Group: Government, industry, academia, media, and other registered participants
Event Date: 06/23/2022
Location: Virtual
Subject: Pharmaceutical Research and Manufacturing of America (PhRMA) Heads of Regulatory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of PhRMA
Event Date: 06/23/2022
Location: Washington, DC
Subject: Duke-Margolis Drug Supply Chain Resilience and Advanced Manufacturing Consortium Kickoff
FDA Participant/Group: JENNIFER MAGUIRE; PETER MARKS; MATTHEW DEFINA; ADAM FISHER;
Non FDA Participant/Group: Industry, regulatory, and other stakeholders
Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
Event Date: 06/21/2022
Location: Virtual
Subject: The European Food Safety Authority’s ONE Health, Environment and Society Conference 2022; Speaker: Food Safety and Consumer Trust
FDA Participant/Group: N/A
Non FDA Participant/Group: European member states, European Food Safety Authority’s international partners, and scientists
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
No Significant Event
Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Erica Jefferson, Associate Commissioner for External Affairs
No Significant Event
Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist
No Significant Event
Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research
Event Date: 06/22/2022
Location: Virtual
Subject: Drug Information Association (DIA) 2022 Global Annual Meeting; FDA Rare Disease Town Hall
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, media, and other registered participants
Event Date: 06/23/2022
Location: Virtual
Subject: Drug Information Association (DIA) 2022 Global Annual Meeting; FDA Town Hall
FDA Participant/Group: RICHARD PAZDUR; PETER MARKS;
Non FDA Participant/Group: Government, industry, academia, media, and other registered participants
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 06/20/2022
Location: Virtual
Subject: Drug Information Association (DIA) 2022 Global Annual Meeting; International Coalition of Medicines Regulatory Authorities (ICMRA): COVID-19 Response and International Collaboration
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, media, and other registered participants
Event Date: 06/21/2022
Location: Virtual
Subject: FasterCures Virtual Event; Advancing Cell and Gene Therapies for Rare Diseases
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, and other registered participants
Event Date: 06/22/2022
Location: Virtual
Subject: Drug Information Association (DIA) 2022 Global Annual Meeting; COVID-19 360°: Embedding Global Best Practices in Routine Regulatory Action and Preparing for the Next Pandemic
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, media, and other registered participants
Event Date: 06/25/2022
Location: Virtual
Subject: CDC/Infectious Diseases Society of America COVID-19 Clinician Call; Pediatric Vaccination
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, and other stakeholders
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
Event Date: 06/21/2022
Location: Virtual
Subject: Reagan-Udall Foundation Nutrition Convening Meeting
FDA Participant/Group: KARI BARRETT; JANESIA ROBBS; ROBIN MCKINNON;
Non FDA Participant/Group: Reagan-Udall Foundation members
Event Date: 06/22/2022
Location: Washington, DC
Subject: Institute for the Advancement of Food and Nutrition Sciences (IAFNS) Annual Meeting and Science Symposium; Speaker: Nutrition Labeling
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders
Official Name: Michele Mital, Acting Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research
No Significant Event
Official Name: Mark Raza, J.D., Chief Counsel
No Significant Event